Treatment of Alcohol Withdrawal in Hospital Patients



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:21 - 75
Updated:4/21/2016
Start Date:April 2001
End Date:May 2003

Use our guide to learn which trials are right for you!

Acute Drug Withdrawal in a General Medical Setting

The purpose of this study is to test how tolerable and effective lorazepam is when used to
treat alcohol withdrawal in hospital patients at risk for alcohol withdrawal.

Studies show that symptom-triggered dosing is best for treatment of alcohol withdrawal in
patients on chemical dependence units without other illness. On general medical hospital
wards, withdrawal may be affected by comorbid medical illness. A clinical trial was
undertaken to determine whether there is a difference between symptom-triggered (ST) and
fixed-schedule (FS) dosing of lorazepam in patients hospitalized on general medical wards at
a University medical center. Subjects were assessed by their nurses with the Revised
Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale. Subjects in the ST arm
received lorazepam doses based on CIWA-Ar score. Subjects in the FS arm received scheduled
lorazepam with tapering over 4 days.

Inclusion Criteria:

- Alcohol dependence (based on criteria from the Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition)

- Daily alcohol use for at least seven consecutive days with the last use no more than
72 hours prior to enrollment

- Patients on the General Internal Medicine service

Exclusion Criteria:

- Unable to give informed consent

- Chronically maintained on prescription sedative-hypnotics
We found this trial at
1
site
1250 E. Marshall St.
Richmond, Virginia 23298
(804) 828-9000
Virginia Commonwealth University Medical Center The Virginia Commonwealth University Health System is an urban, comprehensive...
?
mi
from
Richmond, VA
Click here to add this to my saved trials